Chronic levodopa therapy enhances dopa absorption: Contribution to wearing-off
- 1 October 1996
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 103 (10) , 1177-1185
- https://doi.org/10.1007/bf01271202
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanismsAnnals of Neurology, 1994
- Repeated l-DOPA administration reduces the ability of dopamine storage and abolishes the supersensitivity of dopamine receptors in the striatum of intact ratNeuroscience Research, 1993
- Induction of aromatic‐l‐amino acid decarboxylase by decarboxylase inhibitors in idiopathic parkinsonismAnnals of Neurology, 1989
- Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patientsNeurology, 1987
- Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's diseaseAnnals of Neurology, 1987
- Pharmacokinetics of LevodopaClinical Neuropharmacology, 1984
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- SYNTHETIC AMINO ACIDS AND THE NATURE OF l‐DOPA TRANSPORT AT THE BLOOD‐BRAIN BARRIERJournal of Neurochemistry, 1975
- Intestinal Decarboxylation of Orally Administered L‐dopaActa Medica Scandinavica, 1975
- Enhancement of the pharmacological action of 3,4-dihydroxy-L-phenylalanine (L-DOPA) and reduction of DOPA decarboxylase activity in rat liver after chronic treatment with L-DOPAEuropean Journal of Pharmacology, 1973